Bioequivalence Sample Size is a statistical determination of the minimum number of participants required in a clinical trial to reliably detect equivalence between two pharmacokinetic or pharmacodynamic profiles within a predefined confidence level, specifically in the context of bioequivalence studies.
46
Publications
1.7K
Citations
116
Authors
66
Institutions
Publications per year
2017–2026
4
Parents
Publications
46
1–5 of 46
Authors
116
- SC
8
h-index
- DH
8
h-index
- ED
6
h-index
- VW
6
h-index
- WW
5
h-index
1–5 of 116
Institutions
66
Zimmer Biomet (Germany)
Berlin, Germany
8 h-index
11 publications
786 citations
Klinikum Konstanz
Konstanz, Germany
7 h-index
10 publications
764 citations
Huntsworth Health (United States)
Yardley, United States
4 h-index
4 publications
190 citations
University of Wisconsin–Madison
Madison, United States
3 h-index
4 publications
83 citations
United States Food and Drug Administration
Silver Spring, United States
2 h-index
3 publications
70 citations
Research Triangle Park Foundation
Durham, United States
2 h-index
2 publications
58 citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
2 h-index
4 publications
59 citations
Heidelberg University
Heidelberg, Germany
2 h-index
3 publications
58 citations
1–8 of 66
Venues
- PubMed
Repository · 8 publications · 433 citations
8
h-index
- Statistics in Medicine
6 publications · 129 citations
6
h-index
- Journal of Biopharmaceutical Statistics
JBS · 5 publications · 116 citations
5
h-index
- Pharmaceutical Statistics
4 publications · 102 citations
4
h-index
- Journal of Pharmacokinetics and Biopharmaceutics
3 publications · 120 citations
3
h-index
1–5